Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$342.17 - $402.31 $4,448 - $5,230
-13 Reduced 2.25%
564 $213,000
Q3 2022

Nov 14, 2022

SELL
$343.2 - $395.75 $3,432 - $3,957
-10 Reduced 1.7%
577 $204,000
Q2 2022

Aug 16, 2022

SELL
$269.58 - $378.88 $199,758 - $280,750
-741 Reduced 55.8%
587 $222,000
Q1 2022

Feb 08, 2024

BUY
$254.45 - $351.06 $373,532 - $515,356
1,468 New
1,468 $462,000
Q4 2021

Feb 17, 2022

BUY
$272.01 - $353.03 $361,229 - $468,823
1,328 New
1,328 $465,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.9B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.